Moreover, our study provided novel clues to the possible mechanisms behind the direct activation of immune cells by anti‐PD‐L1 mAb and explained why some patients without expression of PD‐L1 on their tumours still responded to anti‐PD‐L1 mAb treatment. Here, CD274 is linked to neoplasm.